Fufeng Wang

803 total citations
27 papers, 465 citations indexed

About

Fufeng Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fufeng Wang has authored 27 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Fufeng Wang's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Electrohydrodynamics and Fluid Dynamics (5 papers). Fufeng Wang is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (6 papers) and Electrohydrodynamics and Fluid Dynamics (5 papers). Fufeng Wang collaborates with scholars based in China, Canada and Macao. Fufeng Wang's co-authors include Yang Shao, Xue Wu, Zhiying Wang, Mindi Zhang, Biao Huang, Guoyu Wang, Jiani C. Yin, Yan Huang, Huaqiang Zhou and Yunpeng Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Fufeng Wang

24 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fufeng Wang China 11 220 188 114 73 70 27 465
Weiguo Cao China 14 174 0.8× 110 0.6× 205 1.8× 215 2.9× 81 1.2× 38 581
Rou Chen China 13 56 0.3× 71 0.4× 107 0.9× 157 2.2× 40 0.6× 46 455
Huaitao Wang China 12 112 0.5× 53 0.3× 112 1.0× 129 1.8× 32 0.5× 26 359
Chee Lum United States 9 56 0.3× 46 0.2× 31 0.3× 31 0.4× 74 1.1× 16 362
Shanyuan Zhang China 10 148 0.7× 134 0.7× 27 0.2× 39 0.5× 18 0.3× 45 394
Norimichi Okada Japan 14 269 1.2× 58 0.3× 36 0.3× 85 1.2× 169 2.4× 75 569
S. Philippou Germany 9 112 0.5× 67 0.4× 21 0.2× 67 0.9× 94 1.3× 33 395
Jiefei Han China 8 222 1.0× 122 0.6× 84 0.7× 103 1.4× 16 0.2× 20 403
H. Weiß United States 11 61 0.3× 170 0.9× 78 0.7× 57 0.8× 66 0.9× 54 465

Countries citing papers authored by Fufeng Wang

Since Specialization
Citations

This map shows the geographic impact of Fufeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fufeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fufeng Wang more than expected).

Fields of papers citing papers by Fufeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fufeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fufeng Wang. The network helps show where Fufeng Wang may publish in the future.

Co-authorship network of co-authors of Fufeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Fufeng Wang. A scholar is included among the top collaborators of Fufeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fufeng Wang. Fufeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ye, Xin Lv, Fufeng Wang, et al.. (2025). Predictive and prognostic value of genetic aberrations of EGFR-TKI treatment: a real-world analysis of EGFR-mutant non-small cell lung cancer. Journal of Thoracic Disease. 17(10). 8978–8991.
2.
Chen, Jian, Nannan Lu, Song Wang, et al.. (2025). Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis. Breast Cancer Research. 27(1). 64–64. 1 indexed citations
3.
Zhao, Mengke, Yueling Yang, Fufeng Wang, et al.. (2025). Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA. BMC Cancer. 25(1). 1808–1808.
4.
Li, Fangyuan, Yaohui Wang, Jiani C. Yin, et al.. (2024). Molecular evolution of intestinal-type early gastric cancer according to Correa cascade. Journal of Biomedical Research. 39(3). 270–270. 3 indexed citations
5.
Tang, Junwei, Wen Peng, Dongjian Ji, et al.. (2024). Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. International Journal of Surgery. 110(8). 4559–4570. 13 indexed citations
6.
7.
Jiao, Zichen, Xiaoming Shi, Zirui Zhang, et al.. (2024). Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma. Cell Reports Medicine. 5(8). 101664–101664. 5 indexed citations
8.
Liu, Jun, Xiao‐Dan Weng, Jiaping Zhao, et al.. (2023). Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution. Frontiers in Oncology. 13. 1150098–1150098. 4 indexed citations
9.
Zhang, Ying, et al.. (2023). Case Report: Cancer spectrum and genetic characteristics of a de novo germline POLD1 p.L606M variant-induced polyposis syndrome. Frontiers in Oncology. 13. 1222873–1222873. 1 indexed citations
10.
Chen, Xiaofeng, Xiang Xu, Danping Wang, et al.. (2023). Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial. Journal for ImmunoTherapy of Cancer. 11(2). e005830–e005830. 54 indexed citations
11.
Huang, Rong, Gaigai Shen, Yu Ren, et al.. (2023). Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma. Journal of Translational Medicine. 21(1). 78–78. 9 indexed citations
12.
Shan, Benjie, Xinghua Han, Xiaotian Zhao, et al.. (2022). Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer. Frontiers in Oncology. 11. 784985–784985. 19 indexed citations
13.
Zhang, Yan, Wenbin Wei, Junyang Zhao, Xiaolin Xu, & Fufeng Wang. (2022). Spectrum and tissue distribution of RB1 pathogenic alleles in mosaic retinoblastoma patients. Ophthalmic Genetics. 43(6). 795–805.
14.
Cai, Lei, Jiangfeng Wang, Junrong Yan, et al.. (2021). Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma. Frontiers in Oncology. 10. 603671–603671. 11 indexed citations
15.
Qin, Yanru, Hong Jian, Xiaoling Tong, et al.. (2020). Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors. Molecular Oncology. 14(8). 1695–1704. 43 indexed citations
16.
Fang, Wenfeng, Yuxiang Ma, Jiani C. Yin, et al.. (2019). Comprehensive Genomic Profiling Identifies Novel Genetic Predictors of Response to Anti–PD-(L)1 Therapies in Non–Small Cell Lung Cancer. Clinical Cancer Research. 25(16). 5015–5026. 139 indexed citations
17.
Wang, Fufeng & Jianhui Wu. (2019). A low energy switching scheme for SAR ADC with MSB-splitting DAC structure. Analog Integrated Circuits and Signal Processing. 100(1). 199–203. 4 indexed citations
18.
Ding, Yongjie, Hezhi Sun, Yu Xu, et al.. (2017). Effect of oblique channel on discharge characteristics of 200-W Hall thruster. Physics of Plasmas. 24(2). 24 indexed citations
19.
Ding, Yongjie, Hezhi Sun, Liqiu Wei, et al.. (2017). Performance characteristics of No-Wall-Losses Hall Thruster. The European Physical Journal Special Topics. 226(13). 2945–2953. 13 indexed citations
20.
Wang, Fufeng. (2010). Assessment of a Density Modify Based Turbulence Closure for Unsteady Cavitating Flows. Transactions of Beijing Institute of Technology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiguo Cao Breakdown of academic impact, for papers by Rou Chen Breakdown of academic impact, for papers by Huaitao Wang Breakdown of academic impact, for papers by Chee Lum Breakdown of academic impact, for papers by Shanyuan Zhang Breakdown of academic impact, for papers by Norimichi Okada Breakdown of academic impact, for papers by S. Philippou Breakdown of academic impact, for papers by Jiefei Han Breakdown of academic impact, for papers by H. Weiß
Rankless by CCL
2026